Rchr
J-GLOBAL ID:201801009372237487   Update date: Jul. 15, 2024

Seki Masafumi

Seki Masafumi
Research field  (1): Hematology and oncology
Research theme for competitive and other funds  (1):
  • 2017 - 2018 先端的ゲノム・エピゲノム解析を駆使した小児造血器腫瘍における難治化機序の解明
Papers (109):
  • Joana Carrelha, Stefania Mazzi, Axel Winroth, Michael Hagemann-Jensen, Christoph Ziegenhain, Kari Högstrand, Masafumi Seki, Margs S Brennan, Madeleine Lehander, Bishan Wu, et al. Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells. Nature immunology. 2024. 25. 6. 1007-1019
  • Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Aiko Sato-Otsubo, Mitsuteru Hiwatari, Motohiro Kato, Akira Oka, et al. Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism. Oncogene. 2022. 41. 46. 4994-5007
  • 樋渡 光輝, 関 正史, 松野 良介, 吉田 健一, 長澤 武, 佐藤 亜以子, 山本 将平, 加藤 元博, 渡邉 健太郎, 関口 昌央, et al. 神経芽腫における新規TENM 3-ALK融合遺伝子の解析(Novel ALK fusion in neuroblastoma involving TENM3, a conserved family of transmembrane protein). 日本癌学会総会記事. 2022. 81回. J-3016
  • Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, Akira Nishimura, Genta Nagae, Chika Yamagishi, Moe Tamura, Yosuke Tanaka, Shuhei Asada, Reina Takeda, et al. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia. Nature communications. 2022. 13. 1. 4501-4501
  • Ko Kudo, Yasuo Kubota, Tsutomu Toki, Rika Kanezaki, Akie Kobayashi, Tomohiko Sato, Takuya Kamio, Shinya Sasaki, Norio Shiba, Daisuke Tomizawa, et al. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report. Blood advances. 2022. 6. 10. 3162-3166
more...
MISC (111):
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page